These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2937919

  • 1. Concanavalin A induced suppression of lymphocyte proliferation in chronic liver disease. A study of suppressor and responder populations in autologous and allogeneic systems.
    Arabi MA, Nouri-Aria KT, Alexander GJ, Eddleston AL, Williams R.
    J Clin Lab Immunol; 1985 Dec; 18(4):161-5. PubMed ID: 2937919
    [Abstract] [Full Text] [Related]

  • 2. Antigen specific suppressor T cells from chronic hepatitis B virus (HBV) carriers inhibit the responsiveness to HBsAg of allogeneic high-responder lymphocytes.
    Barnaba V, Levrero M, Franco A, Zaccari C, Musca A, Balsano F.
    J Clin Lab Immunol; 1985 Mar; 16(3):137-42. PubMed ID: 3162024
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Disordered immunoregulatory functions in patients with chronic active hepatitis.
    Nonomura A, Tanino M, Kurumaya H, Ohta G, Kato Y, Kobayashi K.
    Clin Exp Immunol; 1982 Mar; 47(3):595-605. PubMed ID: 6211306
    [Abstract] [Full Text] [Related]

  • 6. Immunoregulatory defect in patients with autoimmune thrombocytopenic purpura (ATP).
    Peller S, Kaufman S, Shaked U.
    Thymus; 1986 Mar; 8(6):361-7. PubMed ID: 2949403
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Suppressor cell activity in viral and non-viral chronic active hepatitis.
    Tremolada F, Fattovich G, Panebianco G, Ongaro G, Realdi G.
    Clin Exp Immunol; 1980 Apr; 40(1):89-95. PubMed ID: 6446433
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Loss of suppressor T cell function and circulating immune complexes in chronic active liver diseases.
    Hotta R, Kuriki J, Kakumu S.
    Clin Exp Immunol; 1981 Nov; 46(2):375-81. PubMed ID: 6461458
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increased sensitivity to concanavalin A and a suppressor cell defect in chronic active hepatitis.
    de Galocsy C, Jenkins PJ, Mieli-Vergani G, Eddleston AL, Williams R.
    Clin Exp Immunol; 1981 Mar; 43(3):486-90. PubMed ID: 6456855
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro study of IgG production and concanavalin A induced suppressor cell function in acute and chronic hepatitis B virus infection.
    Nouri-Aria KT, Alexander GJ, Portmann B, Vergani D, Eddleston AL, Williams R.
    Clin Exp Immunol; 1986 Apr; 64(1):50-8. PubMed ID: 2942323
    [Abstract] [Full Text] [Related]

  • 15. T suppressor cell function and number in children with liver disease.
    Nouri-Aria KT, Lobo-Yeo A, Vergani D, Mieli-Vergani G, Eddleston AL, Mowat AP.
    Clin Exp Immunol; 1985 Aug; 61(2):283-9. PubMed ID: 2931221
    [Abstract] [Full Text] [Related]

  • 16. Functional properties of lymphocyte subpopulations in hepatitis B virus infection. I. Suppressor cell control of T lymphocyte responsiveness.
    Chisari FV, Castle KL, Xavier C, Anderson DS.
    J Immunol; 1981 Jan; 126(1):38-44. PubMed ID: 6450240
    [Abstract] [Full Text] [Related]

  • 17. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.
    Eggink HF, Houthoff HJ, Huitema S, Gips CH, Poppema S.
    Clin Exp Immunol; 1982 Oct; 50(1):17-24. PubMed ID: 6983407
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. T cell subsets in autoimmune and HBV-induced chronic liver disease, HBs antigen carriers with normal histology and primary biliary cirrhosis: a review of the abnormalities and the effects of treatment.
    Thomas HC, Brown D, Labrooy J, Epstein O.
    J Clin Immunol; 1982 Jul; 2(3 Suppl):57S-60S. PubMed ID: 6752180
    [Abstract] [Full Text] [Related]

  • 20. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
    Moutsopoulos HM, Fauci AS.
    J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.